VivoSeq
Other

Antibiotics

0

Pipeline Programs↗

32

Active Trials↗

4

Companies Involved↗

Antibiotics is an early-stage landscape with 0 programs across 4 companies. The most active players are Pfizer, Emergent BioSolutions, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

42/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalEmergent BioSolutions logo

Emergent BioSolutions

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalBasilea Pharmaceutica logo

Basilea Pharmaceutica

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

124

clinical trials

Completed59 · 48%
Unknown status18 · 15%
Recruiting18 · 15%
Withdrawn10 · 8%
Not yet recruiting7 · 6%
Active, not recruiting6 · 5%
Other6 · 5%

Clinical Trials

Trial Activity

124 trials

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
Recruiting·SSt. Joseph's Hospital and Medical Center, Phoenix·Phase 4·NCT03014687·116 enrolled
Local Antibiotics for Breast Implants
Recruiting·—·Phase 3·NCT04731025·1,003 enrolled
Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study
Recruiting·HHelse Stavanger HF·Phase 4·NCT06020716·350 enrolled
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
Recruiting·MMontefiore Medical Center·Phase 1·NCT05001750·84 enrolled
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Recruiting·—·Phase 1·NCT05302531·10 enrolled
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
Recruiting·NNorthwestern University·Phase 4·NCT04573504·274 enrolled
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
Recruiting·UUniversity Hospitals Cleveland Medical Center·Phase 4·NCT05345457·88 enrolled
PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4
Recruiting·MMedical University of Vienna·N/A·NCT02652169·120 enrolled
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
Recruiting·RRutgers, The State University of New Jersey·Phase 1·NCT06609980·40 enrolled
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
Recruiting·UUniversity of Geneva, Switzerland·Phase 4·NCT04669717·45 enrolled
Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)
Recruiting·OOhio State University·Phase 4·NCT06706362·138 enrolled
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
Recruiting·RRutgers, The State University of New Jersey·Phase 3·NCT06131021·150 enrolled
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
Recruiting·MMajor Extremity Trauma Research Consortium·Phase 3·NCT05699174·250 enrolled
Prenatal Antibiotics and Breast Milk / Neonatal IgA
Recruiting·FFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico·N/A·NCT05813184·82 enrolled
Prophylactic Antibiotics Duration Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation
Recruiting·UUniversity of Brawijaya·Phase 2·NCT06355115·100 enrolled
Page 1 of 9

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)